Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer

ConclusionAlthough daily fractionated radiation is well established as the standard of care for the treatment of patients with head and neck cancer, how this radiation schema alters antitumor immunity needs further study. If the radiation doses and fractions alter antitumor immunity differently can have profound implications in the rational design of clinical trials investigating whether radiation can enhance response rates to immune checkpoint blockade.
Source: Head and Neck - Category: ENT & OMF Authors: Tags: BASIC SCIENCE REVIEW Source Type: research